鎌状赤血球症(SCD)治療の世界市場2023~2028:産業動向、シェア、規模、成長、機会・予測

◆英語タイトル:Sickle Cell Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書(IMARC23DCB0306)◆商品コード:IMARC23DCB0306
◆発行会社(リサーチ会社):IMARC
◆発行日:2023年11月
◆ページ数:139
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算¥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の鎌状赤血球症(SCD)治療市場規模は2022年に30億ドルに達しました。今後、IMARC Groupは、市場が2028年までに74億ドルに達し、2022年から2028年の間に16.2%の成長率(CAGR)を示すと予測しています。
鎌状赤血球症(SCD)は、全身に酸素を運ぶタンパク質であるヘモグロビンに影響を及ぼす遺伝的な赤血球(RBC)障害です。急性胸部症候群、貧血、血管閉塞性クリーゼ(VOC)など多くの合併症を引き起こします。現在、SCDの治療には血液移植と骨髄移植が一般的に行われています。この移植は、罹患した骨髄をドナーからの健康な骨髄と置き換えるものです。薬物療法や輸血などの他の効果的な治療法も、特定の症状を軽減し、患者の寿命を延ばすことができるため、活用されています。

SCDに罹患する患者数が大幅に増加していることは、SCDを効果的に治療できる新薬の需要に影響を与える重要な要因の一つです。その結果、多くの国の医療規制当局は新しい治療法の迅速な承認に注力しています。例えば、米国食品医薬品局(USFDA)は2019年、SCDの成人および小児が経験する痛みを軽減する新薬を承認しました。さらに、政府当局は研究者や製薬会社に新規治療法の開発を促すため、研究開発(R&D)活動を支援しています。例えば、米国の国立心肺血液研究所(NHLBI)の研究者は、細胞の機能を改善するために、欠損した遺伝子を回復させたり、新しいDNA株を追加したりする遺伝子治療に取り組んでいる。こうした技術革新は、可処分所得の増加や利用可能な医療サービスに関する個人の意識の高まりとともに、市場成長に寄与すると予想されます。

主な市場セグメンテーション
IMARC Groupは、世界の鎌状赤血球症治療市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、治療タイプとエンドユーザーに基づいて市場を分類しています。

治療タイプ別
輸血
薬物療法
骨髄移植

エンドユーザー別
病院
診断センター
その他

地域別
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争環境:
業界の競争環境も、AstraZeneca Plc、Baxter International Inc.、bluebird bio Inc.、Bristol-Myers Squibb Company、CRISPR Therapeutics、Emmaus Medical Inc.、Global Blood Therapeutics Inc.、GlycoMimetics Inc.、Novartis AG、Pfizer Inc.、Sangamo Therapeuticsなどの主要企業のプロフィールとともに調査されています。

本レポートで扱う主な質問
1. 2022年の世界の鎌状赤血球症治療市場規模は?
2. 2023-2028年の鎌状赤血球症治療世界市場の予想成長率は?
3. COVID-19が世界の鎌状赤血球症治療市場に与えた影響は?
4. 世界の鎌状赤血球症治療市場を牽引する主要因は何か?
5. 鎌状赤血球症治療世界市場の治療タイプ別内訳は?
6. 鎌状赤血球症治療世界市場のエンドユーザー別内訳は?
7. 鎌状赤血球症治療の世界市場における主要地域は?
8. 世界の鎌状赤血球症治療市場における主要プレイヤー/企業は?

1. 序論
2. 範囲・調査手法
3. エグゼクティブサマリー
4. イントロダクション
5. 世界の鎌状赤血球症(SCD)治療市場
6. 鎌状赤血球症(SCD)治療の世界市場規模:治療タイプ別
7. 鎌状赤血球症(SCD)治療の世界市場規模:エンドユーザー別
8. 鎌状赤血球症(SCD)治療の世界市場規模:地域別
9. SWOT分析
10. バリューチェーン分析
11. ファイブフォース分析
12. 価格分析
13. 競争状況

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Sickle Cell Disease Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Treatment Type
6.1 Blood Transfusion
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Pharmacotherapy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Bone Marrow Transplant
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by End User
7.1 Hospitals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diagnostic Centers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 AstraZeneca Plc
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Baxter International Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 bluebird bio Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Bristol-Myers Squibb Company
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 CRISPR Therapeutics
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 Emmaus Medical Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.7 Global Blood Therapeutics Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.8 GlycoMimetics Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.9 Novartis AG
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Pfizer Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Sangamo Therapeutics
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis

Figure 1: Global: Sickle Cell Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Sickle Cell Disease Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Sickle Cell Disease Treatment Market: Breakup by Treatment Type (in %), 2022
Figure 5: Global: Sickle Cell Disease Treatment Market: Breakup by End User (in %), 2022
Figure 6: Global: Sickle Cell Disease Treatment Market: Breakup by Region (in %), 2022
Figure 7: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Sickle Cell Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Sickle Cell Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Sickle Cell Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Sickle Cell Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: North America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: North America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: United States: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: United States: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Canada: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Canada: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Asia-Pacific: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Asia-Pacific: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: China: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: China: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Japan: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Japan: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: India: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: India: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: South Korea: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: South Korea: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Australia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Australia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Indonesia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Indonesia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Europe: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Europe: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Germany: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Germany: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: France: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: France: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: United Kingdom: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: United Kingdom: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Italy: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Italy: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Spain: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Spain: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Russia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Russia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Latin America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Latin America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Brazil: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Brazil: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Mexico: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Mexico: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Middle East and Africa: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Middle East and Africa: Sickle Cell Disease Treatment Market: Breakup by Country (in %), 2022
Figure 67: Middle East and Africa: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Global: Sickle Cell Disease Treatment Industry: SWOT Analysis
Figure 69: Global: Sickle Cell Disease Treatment Industry: Value Chain Analysis
Figure 70: Global: Sickle Cell Disease Treatment Industry: Porter's Five Forces Analysis

Table 1: Global: Sickle Cell Disease Treatment Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 3: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 4: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Sickle Cell Disease Treatment Market: Competitive Structure
Table 6: Global: Sickle Cell Disease Treatment Market: Key Players

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 鎌状赤血球症(SCD)治療の世界市場2023~2028:産業動向、シェア、規模、成長、機会・予測(Sickle Cell Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆